| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And Director | President, CEO, Director | President And CEO
1 company
Sherwood Charles H is a CEO And Director at Anika Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2017 | ANIK Anika Therapeutics, Inc. | CEO And Director | Sell | 3,278 | $60.04 | $196,811.12 | -2.4% | |
| Oct 23, 2017 | ANIK Anika Therapeutics, Inc. | CEO And Director | Sell | 28,219 | $60.06 | $1,694,713.32 | -8.7% | |
| Oct 16, 2017 | ANIK Anika Therapeutics, Inc. | CEO And Director | Sell | 3,293 | $60.04 | $197,711.72 | -100% | |
| Oct 13, 2017 | ANIK Anika Therapeutics, Inc. | CEO And Director | Sell | 7,124 | $60.08 | $428,013.76 | -2.1% | |
| Jul 27, 2017 | ANIK Anika Therapeutics, Inc. | CEO And Director | Sell | 63,799 | $50.79 | $3,240,351.21 | -26.7% | |
| Jul 5, 2017 | ANIK Anika Therapeutics, Inc. | President, CEO, Director | Sell | 14,201 | $50.03 | $710,544.16 | -2.8% |